Medical Technology

@xconomy.com 4 years ago

Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug

@xconomy.com 5 years ago

Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M

@xconomy.com 5 years ago

Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug

@xconomy.com 5 years ago

With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug

@xconomy.com 5 years ago

Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug

@xconomy.com 5 years ago

Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision

@xconomy.com 5 years ago

CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”